Sector
PharmaceuticalsOpen
₹2.7Prev. Close
₹2.85Turnover(Lac.)
₹0.03Day's High
₹2.9Day's Low
₹2.752 Week's High
₹052 Week's Low
₹0Book Value
₹-290.46Face Value
₹10Mkt Cap (₹ Cr.)
8.65P/E
0EPS
0Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Equity Capital | 64.37 | 64.37 | 64.37 | 64.37 |
Preference Capital | 76.71 | 76.71 | 76.71 | 76.71 |
Reserves | -747.57 | -626 | -511.62 | -172.14 |
Net Worth | -606.49 | -484.92 | -370.54 | -31.06 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 12.16 | 31.87 | 32.95 | 52.2 |
yoy growth (%) | -61.82 | -3.27 | -36.88 | -64.9 |
Raw materials | -5.66 | -6.32 | -6.76 | -26.02 |
As % of sales | 46.54 | 19.83 | 20.51 | 49.84 |
Employee costs | -14.51 | -19.2 | -16.69 | -15.11 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -154.47 | -141.73 | -119.4 | -125.06 |
Depreciation | -17.32 | -17.34 | -18.56 | -19.1 |
Tax paid | 32.75 | 27.66 | 23.31 | 11.07 |
Working capital | -137.33 | -242.01 | -101.49 | -144.23 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -61.82 | -3.27 | -36.88 | -64.9 |
Op profit growth | -19.83 | -7.3 | -54.16 | -27.09 |
EBIT growth | -8.63 | -3.88 | -35.33 | -18.27 |
Net profit growth | 6.69 | 18.7 | -15.77 | 5.15 |
Particulars (Rupees in Crores.) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|---|
Gross Sales | 8.5 | 12.17 | 31.87 | 32.03 | 217.11 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 8.5 | 12.17 | 31.87 | 32.03 | 217.11 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 52.28 | 0.06 | 0.25 | 1.44 | 1.59 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672.5 | 93.87 | 4,01,372.75 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,938 | 83.3 | 1,84,017.51 | 667 | 0.43 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,488.3 | 24.97 | 1,20,199.04 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,322.4 | 59.44 | 1,12,475.6 | 474 | 0.18 | 2,385 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,283.8 | 19.91 | 1,07,151.95 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Manoharlal Gupta
Whole-time Director
Govind Das Garg
Independent Director
Dharam Pal Khanna
Independent Director
Dilip Kumar Sinha
Non Executive Director
Anil Mittal
Independent Director
Manish Verma
Managing Director & CFO
Vinod Kumar Gupta
Independent Director
Deepali Garhewal
Independent Director
Chhaya Gupta
340 Laxmi Plaza Laxmi Indl Est,
New Link Road Andheri (West),
Maharashtra - 400053
Tel: 91-022-61725900-1
Website: http://www.pdindia.com
Email: pdpl_mumbai@pdindia.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company. In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a c...
Read More
Reports by Parenteral Drugs India Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.